We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+1.06%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$355M
AUM Growth
-$58.3M
Cap. Flow
-$49.6M
Cap. Flow %
-13.96%
Top 10 Hldgs %
19.68%
Holding
1,105
New
222
Increased
181
Reduced
330
Closed
90

Top Buys

Rank Stock Value
1
MCHI icon
iShares MSCI China ETF
MCHI
+$5.54M
2
PICK icon
iShares MSCI Global Metals & Mining Producers ETF
PICK
+$4.8M
3
V icon
Visa
V
+$4.5M
4
ZTS icon
Zoetis
ZTS
+$2.31M
5
WFC icon
Wells Fargo
WFC
+$2.29M

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$24.9M
2
RACE icon
Ferrari
RACE
+$19.1M
3
CNH
CNH Industrial
CNH
+$12.3M
4
IVE icon
iShares S&P 500 Value ETF
IVE
+$8.23M
5
UBS icon
UBS Group
UBS
+$5.09M

Sector Composition

Rank Sector Weight
1 Miscellaneous 18.09%
2 Technology 16.07%
3 Consumer Discretionary 9.4%
4 Healthcare 9.16%
5 Industrials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TBCH
776
Turtle Beach Corp
TBCH
$225M
$1.43K ﹤0.01%
+67
New +$1.4K
AB icon
777
AllianceBernstein
AB
$3.3B
$1.41K ﹤0.01%
30
-2,260
-99% -$105K
WPC icon
778
W.P. Carey
WPC
$15.2B
$1.37K ﹤0.01%
+17
New +$1.3K
FAST icon
779
Fastenal
FAST
$56.3B
$1.37K ﹤0.01%
46
+6
+15% +$168
EWZ icon
780
iShares MSCI Brazil ETF
EWZ
$8.53B
$1.36K ﹤0.01%
36
-54,124
-100% -$1.75M
NI icon
781
NiSource
NI
$19.5B
$1.34K ﹤0.01%
42
-15,055
-100% -$437K
CSGP icon
782
CoStar Group
CSGP
$12.3B
$1.33K ﹤0.01%
20
– –
MTN icon
783
Vail Resorts
MTN
$4.99B
$1.3K ﹤0.01%
+5
New +$1.36K
IGMS
784
DELISTED
IGM Biosciences
IGMS
$1.28K ﹤0.01%
48
– –
ARGT icon
785
Global X MSCI Argentina ETF
ARGT
$793M
$1.28K ﹤0.01%
36
– –
KSA icon
786
iShares MSCI Saudi Arabia ETF
KSA
$614M
$1.28K ﹤0.01%
27
– –
CTAS icon
787
Cintas
CTAS
$79.8B
$1.28K ﹤0.01%
12
– –
CDK
788
DELISTED
CDK Global, Inc.
CDK
$1.27K ﹤0.01%
26
– –
CRSP icon
789
CRISPR Therapeutics
CRSP
$5.05B
$1.25K ﹤0.01%
20
– –
ALL icon
790
Allstate
ALL
$64.4B
$1.25K ﹤0.01%
9
– –
AXSM icon
791
Axsome Therapeutics
AXSM
$11.1B
$1.24K ﹤0.01%
30
– –
CSX icon
792
CSX Corp
CSX
$88.7B
$1.24K ﹤0.01%
33
– –
AVTR icon
793
Avantor
AVTR
$10.6B
$1.22K ﹤0.01%
36
– –
VMI icon
794
Valmont Industries
VMI
$9.18B
$1.19K ﹤0.01%
+5
New +$1.14K
REZI icon
795
Resideo Technologies
REZI
$2.83B
$1.19K ﹤0.01%
50
– –
NGD
796
DELISTED
New Gold Inc
NGD
$1.15K ﹤0.01%
638
– –
HCAT icon
797
Health Catalyst
HCAT
$130M
$1.12K ﹤0.01%
43
– –
ACHC icon
798
Acadia Healthcare
ACHC
$2.62B
$1.11K ﹤0.01%
17
– –
VRSK icon
799
Verisk Analytics
VRSK
$23.7B
$1.07K ﹤0.01%
+5
New +$986
INDA icon
800
iShares MSCI India ETF
INDA
$6.44B
$1.07K ﹤0.01%
24
– –
30 31
32
33 34

Similar funds

PC
Plaisance Capital Denver, Colorado $172M AUM 27.11% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
LPWM
Lake Point Wealth Management Rockwall, Texas $176M AUM 11.87% 1-Year Est. Return
ACM
Aquamarine Capital Management New York $170M AUM 15.49% 1-Year Est. Return
HWIS
Hancock Whitney Investment Services New Orleans, Louisiana $157M AUM
LWM
Loveless Wealth Management Billings, Montana $153M AUM 3.63% 1-Year Est. Return
EW
Emerson Wealth Bloomfield Hills, Michigan $153M AUM 16.38% 1-Year Est. Return
GDWAM
Gold Dragon Worldwide Asset Management Central, Hong Kong $151M AUM 54.24% 1-Year Est. Return

Exane Derivatives's Q1 2022 Portfolio in Review

As of Q1 2022, Exane Derivatives held 1,105 positions worth $355M, down 14% from $413M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Exane Derivatives withdrew a net $49.6M in Q1 2022, closing 90 positions and reducing 330 holdings. Its most notable exit was iShares S&P 500 Value ETF, an estimated $8.23M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Exane Derivatives opened a new position in Visa worth $4.62M.

  • Exane Derivatives's largest Q1 2022 buy was Visa: 20,811 shares worth $4.62M.
  • Exane Derivatives added most to iShares MSCI China ETF in Q1 2022, an estimated $5.54M increase.
  • Exane Derivatives's biggest Q1 2022 reduction was Stellantis, cutting an estimated $24.9M.
  • Exane Derivatives fully exited iShares S&P 500 Value ETF in Q1 2022, selling an estimated $8.23M.
  • Exane Derivatives's ten largest holdings make up 20% of its $355M portfolio in Q1 2022.
  • Exane Derivatives opened 222 new positions and closed 90 in Q1 2022.
  • Exane Derivatives's portfolio value fell 14% quarter-over-quarter to $355M.

Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.